CATR1
CATR tumorigenic conversion 1 protein
Also known as: CATR1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CATR1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
79 residues, UniProt reviewed canonical sequence.
>Q13166|CATR1
1 MVLNEEIPRH LLLTQNNDII PKHHILILPA VDSYQKSVND LRALTFSKFQ ELKHAHELRN
61 LCVSQSRFLA IMWFGTNTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CATR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CATR1 as an antibody target. Whether an autoantibody or antibody against CATR1 could matter depends on whether native CATR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CATR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CATR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...